(Q37092333)

18 August 2017

Campylobacter jejuni strains from patients with Guillain-Barré syndrome (English)

1 reference

18 August 2017

Guillain–Barré syndrome

0 references

1 reference

Campylobacter jejuni

1 reference

5

M J Blaser

1 reference

18 August 2017

B M Allos

1

1 reference

18 August 2017

F T Lippy

series ordinal

2

1 reference

18 August 2017

A Carlsen

series ordinal

3

1 reference

18 August 2017

R G Washburn

series ordinal

4

1 reference

18 August 2017

1 April 1998

1 reference

Emerging Infectious Diseases

18 August 2017

1 reference

18 August 2017

4

1 reference

18 August 2017

2

1 reference

18 August 2017

263-268

1 reference

Campylobacter jejuni infection and the Guillain-Barre syndrome: mechanisms and implications

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640125

Common somatic O and heat-labile serotypes among Campylobacter strains from sporadic infections in the United States.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640125

Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640125

Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640125

A prospective study of acute idiopathic neuropathy. II. Antecedent events

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640125

Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640125

Restriction fragment length polymorphism analysis and random amplified polymorphic DNA analysis of Campylobacter jejuni strains isolated from patients with Guillain-Barré syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640125

Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640125

Susceptibility of Campylobacter isolates to the bactericidal activity of human serum

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640125

Pathogenesis of Campylobacter fetus infections: serum resistance associated with high-molecular-weight surface proteins

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640125

Extraintestinal Campylobacter jejuni and Campylobacter coli infections: host factors and strain characteristics.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640125

Specific Serotype of Campylobacter jejuni Associated with Ouillain-Barre Syndrome

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640125

Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640125

Campylobacter jejuni infection as a cause of the Guillain-Barré syndrome

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640125

Campylobacter jejuni infection and Guillain-Barré syndrome.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640125

Susceptibility of Helicobacter pylori to the bactericidal activity of human serum

3 September 2018

1 reference

12 December 2020

Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains

1 reference

12 December 2020

HLA antigens in the Guillain-Barré syndrome

1 reference

12 December 2020

No association with HLA-DR, -DQ or -DP alleles in Guillain-Barré syndrome

1 reference

12 December 2020

Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome

1 reference

12 December 2020

Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues

1 reference

12 December 2020

HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection

1 reference

12 December 2020

Identifiers

DOI

10.3201/EID0402.980213

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

9621196

1 reference